{"ticker": {"uuid": "395093d7-47d9-4508-a399-02e0430a0407", "symbol": "TECH", "name": "Bio-Techne Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "US markets mixed as tech stocks wobble; Eli Lil...", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPaU10a3p6TGRnNFd2clJVNXpSbnUzcWRkZWRoenFJVF9mU2loYmhMSEhVVFN4ckxtdEM2blg0NmFRTHdQWjV4RmgtNzdvaW9CYXpRWk84b0NFNVplSzZ3TkNvN1p1bHk1QXp2aFdBX1VLTm9jNGVNNVVVcGxMWDJ2bjdUcnhqcHVqUnlZcEJkZUw?oc=5", "source_name": "Pluang", "published_at": "2026-07-16T12:35:12+00:00", "published_display": "16 Jul 2026 12:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SK Hynix shares surge 13% on AI hopes as US tech stocks resume their climb", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOUGIxNS16MnpFT1RUSHlscHBBVnNOLTF3cmxLckNrUFotYUR2dzVFazM4aHpzb1QyX0UwaDZmUWxBT0wtelVpS1prcjVkcE9fSDAyRjFWb0gyX0tOM0JzU1RTR1B5dlJoQ3BGaTdvNnllX2htR3luNE83ZDdaOGg1UmdzT0kwSUp0ZW9udWhGSWl1SzRGMDl6R3pucGNhZnhBclFHU2F4YkZITkR1UEE?oc=5", "source_name": "Reuters", "published_at": "2026-07-15T00:55:00+00:00", "published_display": "15 Jul 2026 00:55", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bio-Techne Corp (TECH) Stock Analysis: Navigating the Biotechnology Landscape Amidst Revenue Challenges", "summary": "Bio-Techne Corp (NASDAQ: TECH) is a significant player in the biotechnology sector, specializing in life science reagents, instruments, and services, with a market capitalization of $11.11 billion. Despite its near annual high stock price and robust free cash flow, the company fa", "url": "https://www.directorstalkinterviews.com/bio-techne-corp-tech-stock-analysis-navigating-the-biotechnology-landscape-amidst-revenue-challenges/4121256174", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-14T01:41:53", "published_display": "14 Jul 2026 01:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Enterprise value to EBITDA forward of Bio-Techne Corporation \u2013 DUS:TE1", "summary": "This article provides financial data for Bio-Techne Corporation (DUS:TE1) focusing on its enterprise value to EBITDA for the forward period. It lists the company on the Dusseldorf Stock Exchange and indicates general market status and available financial information.", "url": "https://www.tradingview.com/symbols/DUS-TE1/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-10T00:08:55", "published_display": "10 Jul 2026 00:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RBC Capital Downgrades Bio-Techne to Sector Perform From Outperform, Adjusts Price Target to $73 From $62", "summary": "RBC Capital has downgraded Bio-Techne (NASDAQ: TECH) from an \"Outperform\" rating to \"Sector Perform.\" The firm also adjusted its price target for Bio-Techne shares, raising it to $73 from $62. This comes amidst a series of recent analyst downgrades for Bio-Techne.", "url": "https://www.marketscreener.com/news/rbc-capital-downgrades-bio-techne-to-sector-perform-from-outperform-adjusts-price-target-to-73-fro-ce7f5eded988f120", "source_name": "marketscreener.com", "published_at": "2026-07-09T07:25:00", "published_display": "09 Jul 2026 07:25", "sentiment": "negative", "sentiment_pct": 36, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RBC Capital downgrades Bio-Techne stock rating on acquisition view", "summary": "RBC Capital has downgraded Bio-Techne Corp. (NASDAQ:TECH)", "url": "https://www.investing.com/news/analyst-ratings/rbc-capital-downgrades-biotechne-stock-rating-on-acquisition-view-93CH-4783027", "source_name": "Investing.com", "published_at": "2026-07-09T06:57:11", "published_display": "09 Jul 2026 06:57", "sentiment": "negative", "sentiment_pct": 35, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio", "summary": "Bio-Techne Corporation (NASDAQ: TECH) has expanded its R&D Systems AI-Engineered Designer Protein portfolio with new heat-stable and hyperactive proteins. These additions are designed to improve reproducibility, consistency, and scalability in advanced cell culture and cell thera", "url": "https://investingnews.com/bio-techne-launches-expanded-rd-systems-ai-engineered-designer-protein-portfolio/", "source_name": "Investing News Network", "published_at": "2026-07-09T02:08:52", "published_display": "09 Jul 2026 02:08", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bio-Techne launches AI-designed proteins to boost cell therapy consistency and scalability", "summary": "Bio-Techne Corporation has launched new AI-engineered proteins designed to improve reproducibility and performance in cell therapy workflows. These proteins, including heat-stable fibroblast growth factors and hyperactive interleukins, aim to enhance stability and activity, addre", "url": "https://pluang.com/en/news-feed/bio-techne-luncurkan-portofolio-protein-desainer-ai-terbaru", "source_name": "Pluang", "published_at": "2026-07-08T12:38:44", "published_display": "08 Jul 2026 12:38", "sentiment": "positive", "sentiment_pct": 86, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Bio-Techne Corporation \u2013 MUN:TE1", "summary": "The article focuses on the \"Enterprise value to EBITDA forward\" financial metric for Bio-Techne Corporation (MUN:TE1) on the Munich Stock Exchange. It provides a snapshot that the market is closed and no trades have occurred for this specific data point, which is part of a larger", "url": "https://www.tradingview.com/symbols/MUN-TE1/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T11:38:45", "published_display": "08 Jul 2026 11:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bio-Techne expands AI-engineered protein portfolio for cell therapy", "summary": "Bio-Techne Corporation has launched five new AI-engineered designer proteins, including FGF-4, FGF-7, FGF-8b, IL-3 Heat Stable, and IL-15 Hyperactive proteins, to enhance cell culture and cell therapy applications by improving stability and activity. These proteins are designed f", "url": "https://www.investing.com/news/company-news/biotechne-expands-aiengineered-protein-portfolio-for-cell-therapy-93CH-4781167", "source_name": "Investing.com", "published_at": "2026-07-08T10:39:10", "published_display": "08 Jul 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bio-Techne expands AI-engineered protein portfolio for cell therapy By Investing.com", "summary": "Bio-Techne Corporation announced the expansion of its R&D Systems AI-Engineered Designer Protein portfolio with five new proteins targeted at cell culture and cell therapy applications. These proteins, including heat-stable FGF and IL proteins, are engineered for enhanced stabili", "url": "https://za.investing.com/news/stock-market-news/biotechne-expands-aiengineered-protein-portfolio-for-cell-therapy-93CH-4360109", "source_name": "Investing.com South Africa", "published_at": "2026-07-08T10:38:59", "published_display": "08 Jul 2026 10:38", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bio-Techne expands designer proteins for cell therapy and organoids", "summary": "Bio-Techne (NASDAQ:TECH) has launched new R&D Systems AI-Engineered Designer Proteins, expanding its portfolio for advanced cell culture and cell therapy workflows. The additions include heat-stable fibroblast growth factors (FGF-4, FGF-7, FGF-8b) and hyperactive cytokines (IL-3,", "url": "https://www.stocktitan.net/news/TECH/bio-techne-launches-expanded-r-d-systems-ai-engineered-designer-p3vdg3td5so0.html", "source_name": "Stock Titan", "published_at": "2026-07-08T10:29:57", "published_display": "08 Jul 2026 10:29", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form DEF 14A Bio-Techne Corp For: 7 July By Investing.com", "summary": "This article announces the filing of Form DEF 14A by Bio-Techne Corp on July 7, 2026. The content provides basic financial market data, including various indices, commodities, and stock performances, alongside a brief mention of the specific SEC filing for Bio-Techne.", "url": "https://ca.investing.com/news/stock-market-news/form-def-14a-biotechne-corp-for-7-july-93CH-4724085", "source_name": "Investing.com Canada", "published_at": "2026-07-07T21:37:21", "published_display": "07 Jul 2026 21:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LCI Industries (NYSE \u2013 LCII), Iridium Communications Inc. (Nasdaq \u2013 IRDM), Bio-Techne Corporation (Nasdaq \u2013 TECH), Arcosa, Inc. (NYSE \u2013 ACA)", "summary": "Brodsky & Smith is investigating potential breaches of fiduciary duties by the Boards of Directors of LCI Industries (LCII), Iridium Communications Inc. (IRDM), Bio-Techne Corporation (TECH), and Arcosa, Inc. (ACA) regarding their proposed acquisitions. The investigations focus o", "url": "https://supplychaindigital.com/globenewswire/3322632", "source_name": "Supply Chain Digital", "published_at": "2026-07-07T00:38:40", "published_display": "07 Jul 2026 00:38", "sentiment": "negative", "sentiment_pct": 36, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of", "summary": "Brodsky & Smith LLC is notifying investors of investigations into four companies: LCI Industries (LCII), Iridium Communications Inc. (IRDM), Bio-Techne Corporation (TECH), and Arcosa, Inc. (ACA). The investigations concern potential breaches of fiduciary duties by the companies' ", "url": "https://www.globenewswire.com/news-release/2026/07/06/3322632/0/en/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-lci-industries-nyse-lcii-iridium-communications-inc-nasdaq-irdm-bio-techne-corporation-nasdaq-t.html", "source_name": "GlobeNewswire", "published_at": "2026-07-06T16:17:48", "published_display": "06 Jul 2026 16:17", "sentiment": "negative", "sentiment_pct": 39, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Bio-Techne Corporation (TECH) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPN21RTXYtMG11S1BSZ0tlekQtODBzQUxmQUIyV3ctQm93YUliQlZOSzRHbjhHWDhJYl9ISXdfSks4RXdKMW0wOWNZWTd1QmgxS3RoYjNobWVGdWw1eE0tUkJaWUtfcWlLeV9JVk9SenBSWHFFVS1RMXRrbFpjN2NZQVRNbmJnbUdNaWtmbkZZUFJtc0ZwRW1FczloRkd6QQ?oc=5", "source_name": "Market source", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQcjZqdzdBcURDdWxCZUtoU1dTaHYtVUFRdlo1a3ZGZGY3a1dBX2x2UVE3Y1hoX1duLXhGU2p0UXU2eTctNng5eFJ5c1M0bHBNQ0VmZTFZanhYU21yTVo0UTQtVENveVV1aWdpc3luUlgza3AyUEI2OGx4aEhXc0pBTHpWUThSYXI1S3RTS21lQ21vWjd6MGY4ZDRwVWlEakc3SmFKN09aM0Rlb2pFT3BNNW1GTExnSElFb2NqR3JhX0J3MlptQy1mMk9IOTZtdS1HU25fLU9aOU9XZi1PRDlkZVI2cnhackHSAewBQVVfeXFMTlc2N3pIUkxDd1NtTlVRMEdac1JNSDF3cUNidkZrTElQREZaUTZjZmFHdUVWYW8wcDg1LThGbnlPb0VQUFI4ZXdjSXR6Ym5DREM1X2lyQUtYTzF3XzBBTGRGcEZQQ3FjLWxCQ0locVM2dGZJR1kxYmlBQXdsbFhfbFFISS1wSUkxQmp4U2d2Z3JHbXRPMUpnajBydTRmNnQzZmF5eEdzOVFRNUdDNVV0aDJQNERCaXN3ZGo1UUc1ZGkwOFYzcDgxS1ltZllDeTFxNFIxT3FyOUxLMFNrLUhtOFNFV0xMYkM5TlpWMzk?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Some Bright Spots In Bio-Techne's (NASDAQ:TECH) Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Who Owns Bio-Techne Corporation? Top Shareholders and Recent Insider Trades", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQbGhVRHYxRGh1aEk4T0lwNjBISGlEVkY3SUgwWnRvWXRqZG9DX3RRQ1VzU25hamFxNFRPX2llQnhVbGFpbWxKcDUzcjJOZUc3c0o2Qjh3czZrWmE2ZFRTMVlmNjBWdzFjQzhtZDdVcmdKRXFWalVLN3BaX18zbXVFX1dnWnlvcEk2QmxtWlJkeTdVclhuSFFsX1kxOXhFeUxfbGc?oc=5", "source_name": "TIKR.com", "published_at": "2026-01-01T08:00:00+00:00", "published_display": "01 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "US markets mixed as tech stocks wobble; Eli Lil...", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPaU10a3p6TGRnNFd2clJVNXpSbnUzcWRkZWRoenFJVF9mU2loYmhMSEhVVFN4ckxtdEM2blg0NmFRTHdQWjV4RmgtNzdvaW9CYXpRWk84b0NFNVplSzZ3TkNvN1p1bHk1QXp2aFdBX1VLTm9jNGVNNVVVcGxMWDJ2bjdUcnhqcHVqUnlZcEJkZUw?oc=5", "source_name": "Pluang", "published_at": "2026-07-16T12:35:12+00:00", "published_display": "16 Jul 2026 12:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SK Hynix shares surge 13% on AI hopes as US tech stocks resume their climb", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOUGIxNS16MnpFT1RUSHlscHBBVnNOLTF3cmxLckNrUFotYUR2dzVFazM4aHpzb1QyX0UwaDZmUWxBT0wtelVpS1prcjVkcE9fSDAyRjFWb0gyX0tOM0JzU1RTR1B5dlJoQ3BGaTdvNnllX2htR3luNE83ZDdaOGg1UmdzT0kwSUp0ZW9udWhGSWl1SzRGMDl6R3pucGNhZnhBclFHU2F4YkZITkR1UEE?oc=5", "source_name": "Reuters", "published_at": "2026-07-15T00:55:00+00:00", "published_display": "15 Jul 2026 00:55", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bio-Techne Corp (TECH) Stock Analysis: Navigating the Biotechnology Landscape Amidst Revenue Challenges", "summary": "Bio-Techne Corp (NASDAQ: TECH) is a significant player in the biotechnology sector, specializing in life science reagents, instruments, and services, with a market capitalization of $11.11 billion. Despite its near annual high stock price and robust free cash flow, the company fa", "url": "https://www.directorstalkinterviews.com/bio-techne-corp-tech-stock-analysis-navigating-the-biotechnology-landscape-amidst-revenue-challenges/4121256174", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-14T01:41:53", "published_display": "14 Jul 2026 01:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Bio-Techne Corporation \u2013 DUS:TE1", "summary": "This article provides financial data for Bio-Techne Corporation (DUS:TE1) focusing on its enterprise value to EBITDA for the forward period. It lists the company on the Dusseldorf Stock Exchange and indicates general market status and available financial information.", "url": "https://www.tradingview.com/symbols/DUS-TE1/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-10T00:08:55", "published_display": "10 Jul 2026 00:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RBC Capital Downgrades Bio-Techne to Sector Perform From Outperform, Adjusts Price Target to $73 From $62", "summary": "RBC Capital has downgraded Bio-Techne (NASDAQ: TECH) from an \"Outperform\" rating to \"Sector Perform.\" The firm also adjusted its price target for Bio-Techne shares, raising it to $73 from $62. This comes amidst a series of recent analyst downgrades for Bio-Techne.", "url": "https://www.marketscreener.com/news/rbc-capital-downgrades-bio-techne-to-sector-perform-from-outperform-adjusts-price-target-to-73-fro-ce7f5eded988f120", "source_name": "marketscreener.com", "published_at": "2026-07-09T07:25:00", "published_display": "09 Jul 2026 07:25", "sentiment": "negative", "sentiment_pct": 36, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RBC Capital downgrades Bio-Techne stock rating on acquisition view", "summary": "RBC Capital has downgraded Bio-Techne Corp. (NASDAQ:TECH)", "url": "https://www.investing.com/news/analyst-ratings/rbc-capital-downgrades-biotechne-stock-rating-on-acquisition-view-93CH-4783027", "source_name": "Investing.com", "published_at": "2026-07-09T06:57:11", "published_display": "09 Jul 2026 06:57", "sentiment": "negative", "sentiment_pct": 35, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio", "summary": "Bio-Techne Corporation (NASDAQ: TECH) has expanded its R&D Systems AI-Engineered Designer Protein portfolio with new heat-stable and hyperactive proteins. These additions are designed to improve reproducibility, consistency, and scalability in advanced cell culture and cell thera", "url": "https://investingnews.com/bio-techne-launches-expanded-rd-systems-ai-engineered-designer-protein-portfolio/", "source_name": "Investing News Network", "published_at": "2026-07-09T02:08:52", "published_display": "09 Jul 2026 02:08", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bio-Techne launches AI-designed proteins to boost cell therapy consistency and scalability", "summary": "Bio-Techne Corporation has launched new AI-engineered proteins designed to improve reproducibility and performance in cell therapy workflows. These proteins, including heat-stable fibroblast growth factors and hyperactive interleukins, aim to enhance stability and activity, addre", "url": "https://pluang.com/en/news-feed/bio-techne-luncurkan-portofolio-protein-desainer-ai-terbaru", "source_name": "Pluang", "published_at": "2026-07-08T12:38:44", "published_display": "08 Jul 2026 12:38", "sentiment": "positive", "sentiment_pct": 86, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Bio-Techne Corporation \u2013 MUN:TE1", "summary": "The article focuses on the \"Enterprise value to EBITDA forward\" financial metric for Bio-Techne Corporation (MUN:TE1) on the Munich Stock Exchange. It provides a snapshot that the market is closed and no trades have occurred for this specific data point, which is part of a larger", "url": "https://www.tradingview.com/symbols/MUN-TE1/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T11:38:45", "published_display": "08 Jul 2026 11:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bio-Techne expands AI-engineered protein portfolio for cell therapy", "summary": "Bio-Techne Corporation has launched five new AI-engineered designer proteins, including FGF-4, FGF-7, FGF-8b, IL-3 Heat Stable, and IL-15 Hyperactive proteins, to enhance cell culture and cell therapy applications by improving stability and activity. These proteins are designed f", "url": "https://www.investing.com/news/company-news/biotechne-expands-aiengineered-protein-portfolio-for-cell-therapy-93CH-4781167", "source_name": "Investing.com", "published_at": "2026-07-08T10:39:10", "published_display": "08 Jul 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bio-Techne expands AI-engineered protein portfolio for cell therapy By Investing.com", "summary": "Bio-Techne Corporation announced the expansion of its R&D Systems AI-Engineered Designer Protein portfolio with five new proteins targeted at cell culture and cell therapy applications. These proteins, including heat-stable FGF and IL proteins, are engineered for enhanced stabili", "url": "https://za.investing.com/news/stock-market-news/biotechne-expands-aiengineered-protein-portfolio-for-cell-therapy-93CH-4360109", "source_name": "Investing.com South Africa", "published_at": "2026-07-08T10:38:59", "published_display": "08 Jul 2026 10:38", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bio-Techne expands designer proteins for cell therapy and organoids", "summary": "Bio-Techne (NASDAQ:TECH) has launched new R&D Systems AI-Engineered Designer Proteins, expanding its portfolio for advanced cell culture and cell therapy workflows. The additions include heat-stable fibroblast growth factors (FGF-4, FGF-7, FGF-8b) and hyperactive cytokines (IL-3,", "url": "https://www.stocktitan.net/news/TECH/bio-techne-launches-expanded-r-d-systems-ai-engineered-designer-p3vdg3td5so0.html", "source_name": "Stock Titan", "published_at": "2026-07-08T10:29:57", "published_display": "08 Jul 2026 10:29", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form DEF 14A Bio-Techne Corp For: 7 July By Investing.com", "summary": "This article announces the filing of Form DEF 14A by Bio-Techne Corp on July 7, 2026. The content provides basic financial market data, including various indices, commodities, and stock performances, alongside a brief mention of the specific SEC filing for Bio-Techne.", "url": "https://ca.investing.com/news/stock-market-news/form-def-14a-biotechne-corp-for-7-july-93CH-4724085", "source_name": "Investing.com Canada", "published_at": "2026-07-07T21:37:21", "published_display": "07 Jul 2026 21:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LCI Industries (NYSE \u2013 LCII), Iridium Communications Inc. (Nasdaq \u2013 IRDM), Bio-Techne Corporation (Nasdaq \u2013 TECH), Arcosa, Inc. (NYSE \u2013 ACA)", "summary": "Brodsky & Smith is investigating potential breaches of fiduciary duties by the Boards of Directors of LCI Industries (LCII), Iridium Communications Inc. (IRDM), Bio-Techne Corporation (TECH), and Arcosa, Inc. (ACA) regarding their proposed acquisitions. The investigations focus o", "url": "https://supplychaindigital.com/globenewswire/3322632", "source_name": "Supply Chain Digital", "published_at": "2026-07-07T00:38:40", "published_display": "07 Jul 2026 00:38", "sentiment": "negative", "sentiment_pct": 36, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of", "summary": "Brodsky & Smith LLC is notifying investors of investigations into four companies: LCI Industries (LCII), Iridium Communications Inc. (IRDM), Bio-Techne Corporation (TECH), and Arcosa, Inc. (ACA). The investigations concern potential breaches of fiduciary duties by the companies' ", "url": "https://www.globenewswire.com/news-release/2026/07/06/3322632/0/en/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-lci-industries-nyse-lcii-iridium-communications-inc-nasdaq-irdm-bio-techne-corporation-nasdaq-t.html", "source_name": "GlobeNewswire", "published_at": "2026-07-06T16:17:48", "published_display": "06 Jul 2026 16:17", "sentiment": "negative", "sentiment_pct": 39, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Bio-Techne Corporation (TECH) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPN21RTXYtMG11S1BSZ0tlekQtODBzQUxmQUIyV3ctQm93YUliQlZOSzRHbjhHWDhJYl9ISXdfSks4RXdKMW0wOWNZWTd1QmgxS3RoYjNobWVGdWw1eE0tUkJaWUtfcWlLeV9JVk9SenBSWHFFVS1RMXRrbFpjN2NZQVRNbmJnbUdNaWtmbkZZUFJtc0ZwRW1FczloRkd6QQ?oc=5", "source_name": "Market source", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Some Bright Spots In Bio-Techne's (NASDAQ:TECH) Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQV0RFb0FlUGpxRG1HU1FvUjhVNC1adUlpc2JwZ3p1bUNDY2dXNzhvWnRUdXJieDZRUHgxRTNEMUVBRUl0QWc4VVFITFU0VWU1RVBLTk1qYk5nSTNQekZic3VaRVdCVng3b2RDN1YyakpCVmF6MzRVb3FqMmd4TnBvWEFHanhfVW12Q0ZHNGJCVWtuWXVLRTZYclN5T3JtbmtaMzQ4VXR0bExSZkFXRUJwUjdyZ0x0UFhkM3F3RUVTankxUHFtU2syM3R0Vm51cldQSTE0Z1FtY3MwNHdT0gHiAUFVX3lxTE1BSzQzMENyZjVhRnVvTmlDbG13QkozajVkTGZrMVRoRXpoT1BLTTlVNEdKTDRBTlNoTzM3aVVOdV9QUFpETE94WmRGUVdZTmNKVzBxajFaN3hRMHVYV3NqVUg5VU5kaklqSEc3T1gyS3cyTTl1ZXdud2hNd1dMOWIyMlN1Z1VaUVY3a3FCbjR2Z0RaVURhb2VYSEwwd0xDcXNYaGVzbXFOOGZNZWw3ZTQ3Z3RHQi1tb0FVRjVDTWpDV3JpTDFUb2VmREFudDVvTUJoSW1fZFJ3ZXR3ZFN4QzNpOEE?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Who Owns Bio-Techne Corporation? Top Shareholders and Recent Insider Trades", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQbGhVRHYxRGh1aEk4T0lwNjBISGlEVkY3SUgwWnRvWXRqZG9DX3RRQ1VzU25hamFxNFRPX2llQnhVbGFpbWxKcDUzcjJOZUc3c0o2Qjh3czZrWmE2ZFRTMVlmNjBWdzFjQzhtZDdVcmdKRXFWalVLN3BaX18zbXVFX1dnWnlvcEk2QmxtWlJkeTdVclhuSFFsX1kxOXhFeUxfbGc?oc=5", "source_name": "TIKR.com", "published_at": "2026-01-01T08:00:00+00:00", "published_display": "01 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 107, "total_relevant": 26, "sentiment_summary": {"positive": 7, "negative": 5, "neutral": 14, "score": 54, "total": 26, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 6.95, "count": 12}, {"event": "earnings", "label": "Earnings", "weight": 4.4, "count": 10}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 7, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 71.3, "latest_week": "2026-07-10", "one_week_move": 0.7, "four_week_move": 32.0, "twelve_week_move": 20.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.287651, "market_dynamics_buy_signal": false, "relative_strength": 5.854393, "fair_value_gap": 10.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 37.338, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.7% over one week, +32.0% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 52, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 6}, {"label": "TradingView", "count": 3}, {"label": "simplywall.st", "count": 3}, {"label": "Pluang", "count": 2}, {"label": "Investing.com", "count": 2}, {"label": "Reuters", "count": 1}, {"label": "DirectorsTalk Interviews", "count": 1}, {"label": "marketscreener.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 18}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}, {"label": "Earnings", "count": 10}, {"label": "Deals and strategy", "count": 2}, {"label": "Analyst action", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "18", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.7% over one week, +32.0% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "US markets mixed as tech stocks wobble; Eli Lil..."}], "updated_at": "2026-07-16T12:47:28.424892+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}